source
- U.S. Health Officials Push Policy to Let Specialty Pharmacies Make Certain Peptide InjectionsThe Department of Health and Human Services has submitted an interim access policy for peptides to the White House, where it will be reviewed by the Office of Management and Budget. The proposal w…
- Bausch + Lomb CEO Brent Saunders exits again, interim CEO Thomas Appio appointedBausch + Lomb announced that CEO Brent Saunders is leaving the eye health company for a second time, less than four years into his latest tenure. The departure was mutually agreed upon by Saunders…